Brief: Genetron Health Establishes Strategic Partnership With Neogenomics To Drive Global Oncology Drug Research And Development
08/11/2021 10:08
Nov 8 (Reuters) - Genetron Holdings Ltd GTH.O :
* GENETRON - ESTABLISHES STRATEGIC PARTNERSHIP WITH
NEOGENOMICS TO
DRIVE GLOBAL ONCOLOGY DRUG RESEARCH AND DEVELOPMENT
Source text for Eikon: ID:nGNX8V6Vj4
Further company coverage: GTH.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Genetron Holdings
See all newsBrief: Genetron Holdings Requested That Trading Of Its ADSs On Nasdaq Be Suspended As Of Close Of Trading On March 28, 2024
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius
U.S. STOCKS ON THE MOVE-Scholar Rock, Target, LL Flooring
U.S. STOCKS ON THE MOVE-First Solar, Genetron, Viasat
Genetron surges on $126 mln deal to go private